Tirz Max 60mg

Tirz Max is labelled as containing tirzepatide, a dual receptor agonist acting on two hormone pathways: GIP (involved in insulin secretion and metabolic regulation) and GLP-1 (involved in appetite regulation and blood-glucose control). Listed strength on the packaging: 60mg in 3mL. This page is for information only — it is not available to order online.

• Acts on two hormone pathways: GIP and GLP-1
• Studied in clinical trials for blood-glucose control and weight management
• Information only — contact us to ask about availability

Tirzepatide activates GIP and GLP-1 receptors. GLP-1 activity is associated with appetite regulation, slower stomach emptying and blood-glucose control; GIP activity is associated with insulin secretion and metabolic regulation.

Commonly reported side effects in clinical trials include nausea, diarrhoea, vomiting and constipation. Do not combine with other appetite-suppressant or glucose-lowering medications without medical supervision. Not suitable during pregnancy or breastfeeding.

• Adults with obesity, overweight with weight-related conditions, or type 2 diabetes, as studied in clinical trials
• Discussions of weight management with a qualified healthcare professional

It is not a routine weight-loss option for healthy, lean individuals and should not be used without appropriate medical oversight.

Discuss approved weight-management options with a qualified healthcare professional. No dosing guidance is given on this page.

Follow the manufacturer’s label for temperature range and expiry. Keep away from heat and light and out of children’s reach.